NYSEAMERICAN:CTEK - CynergisTek Stock Price, Forecast & News

CynergisTek trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CTEK."

CynergisTek Inc (NYSEAMERICAN:CTEK) announced its earnings results on Monday, November, 11th. The company reported ($0.07) EPS for the quarter. The business had revenue of $4.77 million for the quarter, compared to analyst estimates of $5.14 million. View CynergisTek's Earnings History.

CynergisTek is scheduled to release their next quarterly earnings announcement on Wednesday, March 25th 2020. View Earnings Estimates for CynergisTek.

1 equities research analysts have issued 12 month target prices for CynergisTek's shares. Their forecasts range from $7.00 to $7.00. On average, they expect CynergisTek's stock price to reach $7.00 in the next twelve months. This suggests a possible upside of 81.8% from the stock's current price. View Analyst Price Targets for CynergisTek.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CynergisTek in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CynergisTek.

News coverage about CTEK stock has been trending negative on Wednesday, InfoTrie reports. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. CynergisTek earned a news impact score of -2.1 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 3.0 out of 10, meaning that recent media coverage is unlikely to have an effect on the company's share price in the near term. View News Stories for CynergisTek.

CynergisTek saw a increase in short interest during the month of January. As of January 15th, there was short interest totalling 18,800 shares, an increase of 394.7% from the December 31st total of 3,800 shares. Based on an average trading volume of 26,000 shares, the days-to-cover ratio is presently 0.7 days. Currently, 0.2% of the shares of the stock are short sold. View CynergisTek's Current Options Chain.

Some companies that are related to CynergisTek include Northbridge Industrial Services (NBI), Energy Technologies (EGY), Continental Materials (CUO), Xeros Technology Group (XSG), International Corona Capital (IC), Tricorn Group (TCN), Chamberlin (CMH), Associated British Engineering (ASBE) and Alstom (ALO).

Based on aggregate information from My MarketBeat watchlists, some companies that other CynergisTek investors own include AcelRx Pharmaceuticals (ACRX), Genocea Biosciences (GNCA), SeaChange International (SEAC), SMTC (SMTX), Invesco (IVZ), Actinium Pharmaceuticals (ATNM), Allena Pharmaceuticals (ALNA), Digi International (DGII), Ichor (ICHR) and Inovio Pharmaceuticals (INO).

Shares of CTEK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CTEK stock can currently be purchased for approximately $3.85.

CynergisTek has a market capitalization of $39.80 million. CynergisTek employs 292 workers across the globe.View Additional Information About CynergisTek.

The official website for CynergisTek is http://www.cynergistek.com/.

The company can be reached via phone at 949-614-0700.